Chemotherapy reversed PD‐L1/PD‐1 suppression of Tfh cells, permitting CXCL13‐mediated B‐cell recruitment and IL‐21‐driven plasma cell development, hence increasing anti‐tumour immunity. Here, CXCL13 is linked to neoplasm.